Abstract:Objective To study the expression of MicroRNA-133 (miR-133) in QBC939 cholangiocarcinoma cells, to analyze the role of miR-133 in the migration and invasion of cholangiocarcinoma cells, and to explore the possible molecular mechanisms.Methods RT-PCR (real-time PCR) was used to analyze the expression of each subtype of miR-133 in QBC939 cholangiocarcinoma cells in order to select the appropriate subtype for functional experiments. QBC939 cells were divided into three groups: interference group (transfection with miR-133a-5p inhibitor), negative control group (transfection with miR-133a-5p mimic), and blank control group. RT-PCR was used to measure the expression of miR-133a-5p in each group; Transwell assay was used to analyze the migration and invasion of cholangiocarcinoma cells in each group; Western blotting was used to detect the expression of LASP-1 protein family members (LIM, SH3-1 protein) in each group.Results In the three subtypes of miR-133,the relative expression of miR-133a-5p was highest (P < 0.05). The relative expression of mir-133a-5p in the interference group was (0.70 ± 0.08), which was lower than that in the negative control group and blank control group (P < 0.05). Compared with the negative and blank control groups, the number of cell migration (72.0 ± 11.0) and invasion (20.0 ± 3.0) in the interference group was significantly decreased (P < 0.05). Compared with the negative and blank control groups, the interference group exhibited higher expression level of LIM protein and lower expression level of SH3-1 protein (P < 0.05).Conclusion MiR-133a-5p can regulate the expression of LASP-1 protein (LIM protein, SH3-1 protein) in QBC939 cholangiocarcinoma cells. The low expression of miR-133a-5p can inhibit the migration and invasion of QBC939 cells, which may be achieved through the regulation of LASP-1 protein by miR-133a-5p. Mir-133a-5p is expected to become a new target for targeted therapy of cholangiocarcinoma.